Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

NEUROPSYCHIATRIC DISORDERS

Challenging the psychiatry–neurology divide: the case of autoimmune encephalitis

Nature Reviews Neurology volume 18, pages 253–254 (2022)Cite this article

Subjects

A new case series describes a cohort of individuals with severe psychiatric presentations who were diagnosed with ‘possible’ or ‘probable’ autoimmune encephalitis on the basis of neurological examination. Many participants improved after treatment with immunotherapy, highlighting the importance of fostering a closer relationship between the fields of neurology and psychiatry.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. National Institute for Health and Care Excellence. Psychosis and Schizophrenia in Adults: Prevention and Management, https://www.nice.org.uk/guidance/cg178/resources/psychosis-and-schizophrenia-in-adults-prevention-and-management-pdf-35109758952133 (NICE, 2014).

  2. Endres, D. et al. Clinical manifestations and immunomodulatory treatment experiences in psychiatric patients with suspected autoimmune encephalitis: a case series of 91 patients from Germany. Mol. Psychiatry (2022).

  3. Graus, F. et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 15, 391–404 (2016).

    Article  Google Scholar 

  4. Nosadini, M. et al. Use and safety of immunotherapeutic management of N-methyl-d-aspartate receptor antibody encephalitis: a meta-analysis. JAMA Neurol. 78, 1333–1344 (2021).

    Article  Google Scholar 

  5. Cullen, A. E. et al. Influence of methodological and patient factors on serum NMDAR IgG antibody detection in psychotic disorders: a meta-analysis of cross-sectional and case-control studies. Lancet Psychiatry 8, 109–120 (2021).

    Article  Google Scholar 

  6. Scott, J. G. et al. The prevalence and treatment outcomes of antineuronal antibody-positive patients admitted with first episode of psychosis. BJPsych Open 4, 69–74 (2018).

    Article  Google Scholar 

Download references

Acknowledgements

B.R.L. is an honorary consultant psychiatrist at Oxford Health Foundation Trust and receives funding from the NIHR Oxford Health Biomedical Research Centre. B.R.L. thanks P. Harrison and G. Lennox for helpful feedback on the manuscript.

Author information

Authors and Affiliations

  1. Department of Psychiatry, University of Oxford, Oxford, UK

    Belinda R. Lennox

Authors
  1. Belinda R. Lennox
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Belinda R. Lennox.

Ethics declarations

Competing interests

B.R.L. is running a trial of immunotherapy in antibody-positive psychosis, SINAPPS2 (www.sinapps.org.uk), and has received research funding for related research from Janssen.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lennox, B.R. Challenging the psychiatry–neurology divide: the case of autoimmune encephalitis. Nat Rev Neurol 18, 253–254 (2022). https://doi.org/10.1038/s41582-022-00636-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41582-022-00636-7

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing